W
WLC

Latest

Longevity Medicine News

Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.

All longevity clinics diagnostics longevity-clinic-comparison clinics longevity-diagnostics regulation best-longevity-clinics biomarkers clinic comparison evidence evidence-based healthspan industry-news longevity longevity-treatments medical tourism aging research biohacking clinical-trials clinique-la-prairie fountain-life longevity-clinics longevity-industry longevity-science NAD-therapy peptide-therapy preventive-health progevita aging aging-research biological-age BPC-157 business cleveland-clinic clinic-comparison clinical trials epigenetic-clock executive health FDA-regulation hospital-longevity-programs innovation lanserhof longevity clinic cost longevity treatments longevity-medicine longevity-medicine-europe NMN NR plasmapheresis preventive medicine research sha-wellness-clinic stem cell therapy stem cells US-longevity-clinics affordable-longevity-europe aging frailty AI diagnostics AI-drug-discovery ai-medicine allogeneic stem cells Alzheimer-disease AMAALA anti-aging-science anti-aging-treatments ARPA-H Austin-Texas best-longevity-clinics-europe best-longevity-clinics-spain best-longevity-clinics-usa biograph biological age reversal biomarker-testing blood-filtering-therapy buchinger-wilhelmi cellular-senescence centenarians chenot-palace Cleveland Clinic compounding-pharmacies cruise-ship-wellness drug-combo editorial EMA epigenetics european longevity clinics european-longevity-clinics european-wellness evidence-based-medicine executive health program cost executive physical cost executive-health franchises full-body MRI genomics geroscience health assessment Human Longevity human-longevity-inc industry-trends inflammation investment ipamorelin joe-rogan longevity clinic longevity clinic europe longevity clinic regulation longevity health assessment longevity medicine longevity-clinic-cost longevity-clinic-europe longevity-clinic-guide longevity-clinics-expansion longevity-expansion longevity-medical-tourism longevity-ranking longevity-technology longevity-testing longevity-tourism luxury-longevity luxury-wellness-europe marketing mayo-clinic media men health MSC therapy mTOR inhibitors multiomics NAD+ neurodegenerative-disease Niagen oxytocin palazzo-fiuggi patient guide patient safety peptide therapy peptides performance pharmaceutical-industry prevention privacy Progevita programs proteomics protocols rapamycin regenerative regenerative medicine regenerative-medicine regulatory-policy risk Saudi-Arabia screening senolytics SHA Wellness Spain sports medicine startups TGF-beta therapeutic plasma exchange therapeutic-fasting TPE treatment-comparison treatments United States UT Health San Antonio VO2-max Ways2Well wellness
NPR: The government may soon lift restrictions on some peptide treatments Peer-reviewed

FDA Peptide Reclassification 2026: What It Means for Longevity Clinics and Patients

HHS Secretary Kennedy announced ~14 peptides will move from Category 2 (restricted) to Category 1 (legal for compounding). Here's what the reclassification means for longevity medicine, which peptides are returning, and why physician oversight matters more than ever.

peptide-therapy FDA-regulation longevity-treatments